Related Experiment Video
Updated: Feb 18, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Technical Note: Defining cyclotron-based clinical scanning proton machines in a FLUKA Monte Carlo system
Francesca Fiorini1, Niek Schreuder2, Frank Van den Heuvel1
1CRUK - MRC Oxford Institute for Radiation Oncology University of Oxford, Oxford, UK.
This study presents a method to accurately simulate cyclotron-based pencil beam scanning (PBS) proton therapy using Monte Carlo (MC) codes. The developed MC model shows improved accuracy over treatment planning systems (TPS) for dose deposition, enhancing clinical plan verification.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Science
Background:
- Cyclotron-based pencil beam scanning (PBS) proton therapy machines are prevalent but complex to model in Monte Carlo (MC) simulations due to energy degraders.
- Accurate MC simulation is crucial for verifying treatment plans generated by commercial treatment planning systems (TPS).
Purpose of the Study:
- To outline a generalized methodology for characterizing and simulating cyclotron-based PBS proton machines in a general-purpose MC code.
- To enable the generation of clinically relevant treatment plans using MC simulations derived from commercial TPS plans.
- To adapt MC codes for simulating cyclotron-based scanning proton machines for TPS verification and clinical plan improvement.
Main Methods:
- Characterized the beam from a cyclotron-based IBA Proteus Plus system at the Provision Proton Therapy Center using experimental commissioning data.
- Implemented the beam characterization in the FLUKA MC code.
- Validated the FLUKA model using experimental data in water phantoms for single beams and irregular fields, comparing results with RayStation TPS plans.
Main Results:
- MC simulations and TPS plans showed agreement in dose deposition within target areas.
- MC simulations exhibited lower differences in penumbrae at field edges compared to TPS.
- A gamma index of 3%/3 mm never dropped below 95%, indicating good agreement between MC and experimental data.
Conclusions:
- The developed FLUKA beam model accurately describes the experimental beam, demonstrating lower dose differences compared to TPS.
- The MC model can serve as a valuable tool for verifying and improving clinical proton therapy plans.
- The methodology provides a generalized approach for simulating cyclotron-based scanning proton machines in MC codes.
More Related Videos
11:03Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
Published on: May 29, 2017
10:24Neutron Radiography and Computed Tomography of Biological Systems at the Oak Ridge National Laboratory's High Flux Isotope Reactor
Published on: May 7, 2021
Related Concept Videos
Mass Analyzers: Common Types
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...